Mounjaro 2.5mg is a prescription injectable medication containing Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is primarily used to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. It may also support weight management in some patients under medical supervision.
---
Uses:
Helps lower blood sugar levels in adults with type 2 diabetes
Improves insulin sensitivity
Supports weight loss in some patients
Reduces risk of diabetes-related complications when used consistently
---
Dosage & Administration:
Starting dose: 2.5mg once weekly by subcutaneous injection (under the skin) in the abdomen, thigh, or upper arm.
Dosage may be gradually increased by a healthcare professional depending on treatment response.
Should be taken on the same day each week.
Do not self-adjust dosage without medical guidance.
---
Side Effects:
Common side effects may include:
Nausea, vomiting, or diarrhea
Reduced appetite
Constipation
Abdominal pain
Serious but rare side effects may include:
Pancreatitis (severe abdominal pain)
Gallbladder problems
Allergic reactions
Thyroid tumors (reported in animal studies)
👉 Seek immediate medical attention if you experience difficulty breathing, swelling of the face/throat, or persistent severe abdominal pain.
---
Precautions:
Not recommended for people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
Not for use in type 1 diabetes or for treating diabetic ketoacidosis
Inform your doctor if you are pregnant, breastfeeding, or planning pregnancy
Use with caution if you have kidney or gastrointestinal problems
---
Storage:
Store in a refrigerator (2°C – 8°C).
Do not freeze.
Keep away from direct sunlight.
